Table I.

Patient demographics at the start of deferasirox treatment

Characteristic	All patients (n =185)
Mean age (range), years	19·2 (3·0–54·0)
Age group, n (%)
<6 years	5 (2·7)
6–<12 years	42 (22·7)
12–<16 years	43 (23·2)
16–<50 years	91 (49·2)
50–<65 years	4 (2·2)
Male:female, n	74:111
Caucasian:black:other, n	11:167:7
History of splenectomy, n (%)	24 (13·0)
Median serum ferritin (range), μg/l	3329 (405–12,901)
Serum ferritin, n (%)
500–1000 μg/l	3 (1·6)
> 1000–2500 μg/l	61 (33·0)
>2500–4000 μg/l	48 (25·9)
>4000 μg/l	73 (39·5)